Inflammatory microenvironment impairs the therapeutic effect of daratumumab-lenalidomide in multiple myeloma
Cheng, W.; Gaggero, S.; Hasan Bou Issa, L.; Ouelkdite, A.; Escure, G.; Cozzani, A.; Njosse Tchantchou, Y.; Carlier, N.; Wauquier, E.; Decool, G.; Tilmont, R.; Podvin, B.; Leprohon, M.; Flechon, L.; Kasprowicz, A.; Groux-Degroote, S.; Moreaux, J.; Arnulf, B.; Corre, J.; Villenet, C.; Martinet, L.; Leleu, X.; Figeac, M.; Facon, T.; Jin, W.; Mitra, S.; Manier, S.
Show abstract
Daratumumab and lenalidomide (DR) combination therapy improves multiple myeloma outcomes, yet some patients respond poorly. We examined 56 DR pre-treatment samples from the IFM2017 Phase 3 trial using multiomics approaches to identify determinants of response. Analysis of bone marrow environment revealed critical synergy between inflamed myeloma cells and inflammatory immune microenvironment contributing to treatment failure. We identified non-responders exhibiting inflammatory signatures with impaired monocyte phagocytosis, upregulated NF-kB signaling in monocytes, increased pro-inflammatory ISG+ T cells, and attenuated NK cell CD16 expression--undermining antibody-dependent cellular cytotoxicity essential for daratumumab efficacy. Concurrently, myeloma cells displayed enhanced NF-kB activation, creating an inflammatory circuit. We developed a model based on 34 NF-kB-related genes (AUC=0.96) discriminating responders from non-responders. A refined eight-gene signature was robustly validated using bulk RNA sequencing in bone marrow and peripheral blood cohorts (AUCs=0.92 and 0.77, respectively). These findings suggest anti-inflammatory strategies may enhance treatment efficacy.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- CXCL8 secreted by immature granulocytes inhibits wildtype hematopoiesis in chronic myelomonocytic leukemia 96%
- Disturbing immune homeostasis by neutrophil loss of Uba1 induces VEXAS-like autoinflammatory disease in mice 94%
- Expansion, persistence and efficacy of donor memory-like NK cells for the treatment of post-transplant relapse 94%
Similar papers in this journal
- Single-cell transcriptomic analyses define distinct peripheral B cell subsets and discrete development pathways 95%
- ScRNA-Seq study of neutrophils reveals vast heterogeneity and breadth of inflammatory responses in severe COVID-19 patients 95%
- BCR, not TCR, repertoire diversity is associated with favorable COVID-19 prognosis 94%
Similar papers in this journal
- Gene interaction network analysis in multiple myeloma detects complex immune dysregulation associated with shorter survival 95%
- Integrative molecular profiling identifies two molecularly and clinically distinct subtypes of blastic plasmacytoid dendritic cell neoplasm 94%
- B Cell Receptor Signaling Drives APOBEC3 Expression Via Direct Enhancer Regulation in Chronic Lymphocytic Leukemia B Cells 93%
Similar papers in this journal
- Single Cell Spatial Transcriptomics Reveals Immunotherapy-Driven Bone Marrow Niche Remodeling in AML 95%
- Integrating Single-Cell Biophysical and Transcriptomic Features to Resolve Functional Heterogeneity in Mantle Cell Lymphoma 95%
- N-MYC regulates Cell Survival via eIF4G1 in inv(16) Acute Myeloid Leukemia 94%
Similar papers in this journal
- Daratumumab induces mechanisms of immune activation through CD38+ NK cell targeting 95%
- Mesenchymal stem cells suppress leukemia via macrophage-mediated functional restoration of bone marrow microenvironment 94%
- The Splicing Factor PTBP1 interacts with RUNX1 and is Required for Leukemia Cell Survival 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.